Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Jonathan Rees and colleagues in the Surgical Intervention Trials Unit (SITU) have just been awarded a £1.5 million National Institute of Health Research HTA grant for the PRoCuRe trial to explore the benefits of surgical repair of partial rotator cuff tendon tears of the shoulder.

Professor Jonathan Rees

Rotator cuff problems are the most common cause of shoulder pain and disability, affecting people with day to day activities, work, recreation and sleep. These tears can be full tears through the whole tendon or only partially through. Partial tears are usually treated in the NHS first with physiotherapy and a steroid injection but then surgery if the patient does not get better.

Professor Rees, Section Head Orthopaedic and Plastic Surgery at the Botnar Research Centre, NDORMS says: "Surgery for full tears is one of the most common shoulder operations in the UK but for partial tears we still don't know if surgical repair gives patients a better result in the short term, or whether it prevents full tears developing in the long term. UK patients and surgeons have prioirtised a need to answer this question which is why this trial has been funded by the HTA."

The PRoCuRe trial will take place across 20 NHS hospitals in the UK, recruiting adult patients , who have partial tears of the rotator cuff tendon and persistent shoulder pain after physiotherapy and injection treatments. The randomised controlled trial will compare arthroscopic (keyhole) surgery that cleans, tidies and repairs the tear, to a procedure that just cleans and tidies the tear. The team will monitor how well patients recover firstly over 2 years and then over 5 years.

Similar stories

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

AVID-CC trial opens to recruitment!

OCTRU

The AVID-CC trial has received OCTRU Green Light approval and is now open to recruitment!

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

Vascular loss shown to be the primary hallmark of aging

Kennedy Main Tissue remodelling and regeneration

New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.